Cambridge Neuroscience EventThis event profile is in the events archive.
The Cambridge Clinical Neuroscience and Mental Health SymposiumWhen29th - 30th September 2009WhereWest Road Concert Hall, CambridgeDescription
The Symposium will present the science and practice of brain sciences and mental health with an emphasis on disorders that are common and place a large burden on society. We have selected six cross-cutting themes that highlight the principles of contemporary translational neuroscience. Symposium Sessions include:
We have an exciting line up of local and international speakers, who will discuss their research on Addiction, Alzheimer's and Dementia, Depression, Huntington's Disease, Mood Disorders, Multiple Sclerosis, Obesity, Pain, Parkinson's Disease, Schizophrenia, Spinal Cord Injury and Stroke. This event provides an opportunity for Cambridge Neuroscientists to present their work to colleagues as well as be inspired by the latest research from leaders in the field. To present a scientific poster at this Symposium please submit your abstract, via the registration page, by the 30th June 2009. The first day of the main Symposium (29th September) will conclude with a public music recital orchestrated by Dr. Cheryl Frances-Hoad, Composer in Residence at the Department of Psychiatry, Cambridge. The second day (30th September) will close with a Cambridge Neuroscience dinner and Ceilidh Dance. Back to topPlenariesWith Plenary Lectures by:
Dr. Daniel Weinberger, National Institute of Health, U.S.A. The simple truth about the genetic complexity of schizophrenia Selective motor control and focal dystonia Emotion, value and the tyranny of choice Conflict between brain circuits Controlling stem cells in health and disease Neurological Studies of Rewards Processing In Major Depression Programme at a GlanceIn addition to Plenary Lectures we have outstanding local scientists presenting their work in the Cambridge Clinical Neuroscience and Mental Health fields. Please click here for the full symposium programme and event website. Back to topDirectionsPlease click here for the map. Back to topRegistrationRegistration for the Cambridge Clinical Neuroscience and Mental Health Symposium is now closed, with the venue at full capacity and over 500 delegates registered and over scientific 80 posters on display. Click here to register for this event.Back to top SponsorsWe are grateful to the following for their generous support, making this event possible: Astrazeneca, Brain, Cambridge University Press, The Gatsby Charitable Foundation, GlaxoSmithKline (Neurosciences CEDD and the Clinical Unit Cambridge), Merck, Medical Research Council, Multiple Sclerosis Society, the Wellcome Trust. Further eventsGo to the events index page. |
We are pleased to announce the Cambridge Clinical Neuroscience and Mental Health Symposium, 29th - 30th September 2009, to be held at the West Road Concert Hall, Cambridge.
Dr. Weinberger is Director of the Genes, Cognition, and Psychosis Program of the Intramural Research Program, National Institute of Mental Health, National Institutes of Health in Bethesda, Maryland.
Dr. Hallett obtained his M.D. at Harvard University and trained in Neurology at Massachusetts General Hospital. He had fellowships in Neurophysiology at the National Institutes of Health and at the Institute of Psychiatry in London. From 1976 to 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women's Hospital and Associate Professor of Neurology at Harvard Medical School. From 1984, he has been at the National Institute of Neurological Disorders and Stroke where he serves as Chief of the Human Motor Control Section and pursues research on the Physiology of Human Movement Disorders and other problems of Motor Control. He also served as Clinical Director of NINDS until July 2000. He is past President of the American Association of Electrodiagnostic Medicine and the Movement Disorder Society. He also served as Vice-President of the American Academy of Neurology. He is an Associate Editor of Brain and has just taken over as the Editor in Chief of World Neurology. Currently he also serves on the editorial boards of Clinical Neurophysiology, Acta Neurologica Scandinavica, Journal of Clinical Neurophysiology, Medical Problems of Performing Artists, Annals of Neurology, The Cerebellum, NeuroTherapeutics, and European Neurology. The main work of his group focuses on the physiology and pathophysiology of movement. Dr. Hallett's interests in Motor Control are wide-ranging, and include brain plasticity and its relevance to neurological disorders and the pathophysiology of dystonia, parkinsonism, and myoclonus. Recently he has become interested in disorders of volition, including tic and psychogenic movement disorders.
Ray Dolan is Mary Kinross Professor of Neuropsychiatry at UCL and Director of the Wellcome Trust Centre for Neuroimaging at UCL. His research is concerned with a neurobiological characterisation of human emotion and how it interacts with other components of cognition, particularly attention memory and decision making. An emphasis in his recent work has been to link activation patterns seen during functional neuroimaging experiments to theoretical models, particularly models from reinforcement learning theory. He is among the top 5 most cited scientists in the world in the field of Neuroscience and Behaviour, and the author of 350 original papers. He is the recipient of numerous awards and prizes including an Alexander Von Humboldt Research International Research Award for Outstanding Scholars (2004), the Kenneth Craik Research Award (2006), the Minerva Foundation Golden Brain Award (2006) and the prestigious International Max Planck Research Award (2007).
Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world's research on the health aspects of drug abuse and addiction.
Dr. McKay received a B.Sc. in 1971 and a Ph.D. in 1974 from the University of Edinburgh, where he studied under the tutelage of Edwin Southern examining DNA organization and chromosome structure. He received postdoctoral training at University of Oxford working with Walter Bodner examining restriction fragment length polymorphism (RFLPs). In 1978 he became a senior staff investigator at Cold Spring Harbor Laboratory concentrating on two areas: the interaction of SV40 T-antigen with the specific binding site at the viral origin of replication and the molecular organization of the nervous system. Joining the MIT faculty in 1984, Dr. McKay continued to examine different aspects of neuronal organization in the nervous system. In 1993 he came to NINDS as chief of the Laboratory of Molecular biology. His laboratory is studying stem cell differentiation.
Dr. Drevets will give the 2009 Paykel Lecture on the 28th September, 6:30 pm at the Martin Cohen Lecture Theatre, Cancer Research UK, Cambridge Research Institute.